FIBROGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.04 USD | +1.96% |
|
-9.57% | +17.34% |
Chart calendar FibroGen, Inc.
f94970d61efd71fa.77Y8YvioEKhuHqAorSozPjk_Hu9DlPmKUboWjL--NSo.hMZMJs7JY5wfadl8xXlsaEN-UosypJfkCP14_-jxeB-FxU8TzJx121x67Q~bff34b6fbf64af73d6644e28284d120d
Upcoming events on FibroGen, Inc.
Past events on FibroGen, Inc.
| 10/04/2024 12:30 am | Needham Healthcare Conference |
| 27/02/2024 03:30 am | Q4 2023 Earnings Call |
| 26/02/2024 | Q4 2023 Earnings Release After hours |
| 13/02/2024 09:00 pm | Investor Meeting - KOL |
| 07/11/2023 03:30 am | Q3 2023 Earnings Call |
| 07/11/2023 02:31 am | Q3 2023 Earnings Release |
| 08/08/2023 02:30 am | Q2 2023 Earnings Call |
| 08/08/2023 01:31 am | Q2 2023 Earnings Release |
| 03/07/2023 | Investor Meeting |
| 12/06/2023 11:50 pm | Goldman Sachs Global Healthcare Conference |
| 09/06/2023 12:00 am | Jefferies Global Healthcare Conference |
| 07/06/2023 08:30 pm | Annual General Meeting |
| 09/05/2023 02:30 am | Q1 2023 Earnings Call |
| 09/05/2023 01:31 am | Q1 2023 Earnings Release |
| 08/03/2023 09:00 pm | Cowen Health Care Conference |
| 28/02/2023 03:30 am | Q4 2022 Earnings Call |
| 28/02/2023 02:30 am | Q4 2022 Earnings Release |
| 17/02/2023 02:10 am | SVB Securities Global Biopharma Conference |
| 08/12/2022 11:35 pm | Bank of America Biotech SMID Cap Conference |
| 16/11/2022 12:20 am | Stifel Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 257 285 -9.84% | 176 212 -16.87% | 235 268 -12.06% | 141 131 7.5% | 148 164 -9.94% | 155 |
|
EBITDA Million USD | Released Forecast Spread | -78,2 -6,18 -1164.84% | -170 -126 -34.81% | -274 -212 -29.05% | -290 -314 7.52% | -259 -245 -6.02% | -135 |
|
EBIT Million USD | Released Forecast Spread | -89,3 -36,7 -143.48% | -192 -163 -17.86% | -289 -219 -31.97% | -301 -324 7.21% | -269 -257 -4.72% | -132 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -76,6 -29,1 -163.01% | -189 -163 -15.98% | -291 -218 -33.23% | -295 -318 7.38% | -287 -231 -23.99% | -142 |
|
Net income Million USD | Released Forecast Spread | -77,0 -29,5 -161.32% | -189 -160 -18.26% | -290 -218 -33.01% | -294 -318 7.57% | -284 -230 -23.65% | -142 |
|
EPS USD | Released Forecast Spread | -0,89 -0,34 -161.76% | -2,11 -1,72 -22.94% | -3,14 -2,39 -31.38% | -3,14 -3,38 7.15% | -2,92 -2,56 -14.06% | -1,42 |
| Announcement Date | 02/03/20 | 01/03/21 | 28/02/22 | 27/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,5 47,7 -65.28% | 60,8 28,8 111.51% | 29,8 36,2 -17.56% | 15,7 31,6 -50.19% | 34,4 24,0 43.48% | 36,2 31,5 14.71% | 44,3 34,8 27.4% | 40,1 36,8 8.94% | 27,1 38,8 -30.03% | 36,4 | 37,5 | 41,5 | 37,7 |
|
EBITDA Million USD | Released Forecast Spread | -133 -67,5 -96.63% | -60,4 -76,6 21.16% | -75,6 -80,7 6.34% | -91,0 -68,5 -32.9% | -73,1 -75,5 3.11% | ||||||||
|
EBIT Million USD | Released Forecast Spread | -135 -66,5 -103.41% | -63,0 -78,6 19.88% | -78,2 -86,7 9.8% | -93,7 -77,5 -20.79% | -66,2 -89,5 26.05% | -76,1 -71,6 -6.2% | -88,0 -66,3 -32.78% | -50,9 -67,1 24.19% | -54,2 -43,0 -26.07% | -40,4 | -39,1 | -32,4 | -33,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -134 -63,4 -111.76% | -63,4 -89,4 29.03% | -73,2 -94,9 22.87% | -91,9 -82,0 -12.08% | -66,3 -89,9 26.23% | -77,4 -73,8 -4.89% | -88,5 -73,2 -20.94% | -64,2 -64,2 -0.01% | |||||
|
Net income Million USD | Released Forecast Spread | -134 -64,1 -109.13% | -63,2 -89,4 29.33% | -72,6 -94,9 23.47% | -91,7 -79,2 -15.7% | -66,2 -90,0 26.46% | -76,7 -74,5 -2.9% | -87,7 -74,5 -17.77% | -63,6 -65,0 2.06% | |||||
|
EPS USD | Released Forecast Spread | -1,45 -0,71 -105.38% | -0,68 -0,92 26.09% | -0,78 -0,97 19.79% | -0,98 -0,82 -19.03% | -0,70 -0,95 26% | -0,81 -0,79 -2.86% | -0,90 -0,74 -22.03% | -0,65 -0,67 2.5% | -0,57 -0,43 -32.56% | -0,53 | -0,48 | -0,37 | -0,41 |
| Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 07/08/23 | 06/11/23 | 26/02/24 | - | - | - | - |
More events
Past sector events for FibroGen, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FGEN Stock
- Calendar FibroGen, Inc.
